Melnyk had no intention to mislead Biovail investors: lawyer
A lawyer for Eugene Melnyk, the owner of the Ottawa Senators, says his client didn’t intent to mislead stockholders in his former company, Biovail Corp. when he reported the financial impact of a highway traffic collision that delayed a drug shipment.
Melnyk had no intention to mislead Biovail investors: lawyer
Social Sharing
·
Posted: Jun 25, 2009 4:28 PM ET | Last Updated: June 25, 2009
A lawyer for Eugene Melnyk, the owner of the Ottawa Senators, says his client didn’t intent to mislead stockholders in his former company, Biovail Corp. when he reported the financial impact of a highway traffic collision that delayed a drug shipment.
Kent Thomson spoke before an Ontario Securities Commission panel hearing allegations that Melnyk, the former Biovail CEO, had given incorrect financial information to investors.
Thomson said that his client had been caught up in the uncertainty and chaos of the collision and was operating to the best of his ability when he relied on the expertise of his fellow executives to offer a loss estimate.
The estimate wound up being much greater than the actual loss.
The multiple-vehicle crash happened outside Chicago on Oct. 1, 2003, and involved a shipment of Wellbutrin XL antidepressant pills, which was then delayed.
At issue is an Oct. 3, 2003, news release in which Biovail said it would fall short of investor expectations for sales and earnings in the quarter that ended Sept. 30. As a result of the miss, Biovail’s shares plunged on the Toronto Stock Exchange. The stock, which was well above $50 for months before the earnings shortfall, lost nearly $9 after the crash.
“That’s how a chief executive [operates], he relies on his people,” Thomson told the court as Melnyk sat nearby.
Thomson said that finding Melnyk responsible for the financial calculations that were later found to be wrong would set a dangerous precedent for executives.
“CEOs are going to run for the hills,” he told the court in his closing remarks.
“There is simply no way Mr. Melnyk could have checked or double-checked every calculation provided to him.”
Loss greatly overstated
In the October press release, Biovail had said the crash would reduce third-quarter revenue by between $10 million and $20 million US. Later in its 2003 full-year report, the company changed its position and said that the actual loss was determined to be $5 million.
The commission alleges that this shipment could never have counted in third-quarter results and contends that Melnyk used the crash to divert attention from other woes with Wellbutrin, which included production snags.
Thomson told the court that Melnyk was an entrepreneur who dropped out of school in Grade 12 after his father died, and was not a financial expert.
He said Melnyk didn’t have training in disclosure obligations, but was instead trying to give investors as much information as possible amid the developing details of the highway traffic crash.
On Wednesday, Thomson argued that uncertainty surrounded a shipping term called “freight on board,” which determined who was financially responsible for the drugs after they left Biovail’s plant in Manitoba en route to U.S. distributor GlaxoSmithKline, Thomson said.
Thomson said GlaxoSmithKline was ultimately responsible for the drugs, which is why the loss was eventually revised.
He said the drugs were being shipped in a truck that was operating a controlled temperature environment, as per GlaxoSmithKline’s request, to ensure the composition of the chemicals weren’t changed.
OSC lawyers wrapped up their case on Wednesday, telling the panel that Melnyk had enough information available to him to question the initial calculations made by Biovail’s chief financial officer concerning the value of the product damaged in the crash.
Source URL: Read More
The public content above was dynamically discovered – by graded relevancy to this site’s keyword domain name. Such discovery was by systematic attempts to filter for “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. When possible, this site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain name. Additionally, when possible, this site references the content above to provide on-demand (multilingual) translations and/or to power its “Read Article to Me” feature, which reads the content aloud to visitors. Where applicable, this site also auto-generates a “References” section, which appends the content above by listing all mentioned links. Views expressed in the content above are solely those of the author(s). We do not endorse, offer to sell, promote, recommend, or, otherwise, make any statement about the content above. We reference the content above for your “reading” entertainment purposes only. Review “DMCA & Terms”, at the bottom of this site, for terms of your access and use as well as for applicable DMCA take-down request.
Acquire this Domain
You can acquire this site’s domain name! We have nurtured its online marketing value by systematically curating this site by the domain’s relevant keywords. Explore our content network – you can advertise on each or rent vs. buy the domain. Buy@TLDtraders.com | Skype: TLDtraders | +1 (475) BUY-NAME (289 – 6263). Thousands search by this site’s exact keyword domain name! Most are sent here because search engines often love the keyword. This domain can be your 24/7 lead generator! If you own it, you could capture a large amount of online traffic for your niche. Stop wasting money on ads. Instead, buy this domain to gain a long-term marketing asset. If you can’t afford to buy then you can rent the domain.
About Us
We are Internet Investors, Developers, and Incubators- operating a content network of several thousand sites while federating 20+ eCommerce and SaaS startups. With our proprietary “inverted incubation” model, we leverage a portfolio of $15M+ in valued domains to impact online trends, traffic, and transactions. We use robotic process automation, machine learning, and other proprietary approaches to power our content network. Discover our work!